CDK1 and brain cancer: Previous studies have suggested that in brain cancer cells, cell-cycle arrest was achieved by downregulating the expression of cdc2 and cyclin B1 proteins and disrupting the cdc2/cyclin B1 complex through the upregulation of GADD45β [26].